Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Evans

Showing results (611-620 of 621) with videos related to

Pageof 63
Sort By:
International Journal of Cancer|October 15, 2019
Interval breast cancer risk associations with breast density, family history and breast tissue agingTuong L Nguyen, Shuai Li, Gillian S Dite, et al.
The Journal of Clinical Investigation|December 21, 2023
Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodelingSusan M Lin, Ryan Rue, Alexander R Mukhitov, et al.
American Journal of Human Genetics|October 10, 2025
COMPADRE: Combined pedigree-aware distant relatedness estimation for improved pedigree reconstructionGrahame F Evans, James T Baker, Lauren E Petty, et al.
Breast Cancer Research : BCR|October 26, 2023
Causal relationships between breast cancer risk factors based on mammographic featuresZhoufeng Ye, Tuong L Nguyen, Gillian S Dite, et al.
Nature Communications|November 7, 2020
mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function declineKseniya Obraztsova, Maria C Basil, Ryan Rue, et al.
The Journal of Biological Chemistry|June 14, 2000
Characterization of the human cysteinyl leukotriene 2 receptorC E Heise, B F O'Dowd, D J Figueroa, et al.
International Journal of Cancer|November 16, 2020
Novel mammogram-based measures improve breast cancer risk prediction beyond an established mammographic density measureTuong L Nguyen, Daniel F Schmidt, Enes Makalic, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitorP Prasit, Z Wang, C Brideau, et al.
Nature|July 3, 1999
Characterization of the human cysteinyl leukotriene CysLT1 receptorK R Lynch, G P O'Neill, Q Liu, et al.
Nature|July 14, 2000
Identification of receptors for neuromedin U and its role in feedingA D Howard, R Wang, S S Pong, et al.
Pageof 63

Showing results (611-620 of 621) with videos related to

Sort By:
Pageof 63
International Journal of Cancer|October 15, 2019
Interval breast cancer risk associations with breast density, family history and breast tissue agingTuong L Nguyen, Shuai Li, Gillian S Dite, et al.
The Journal of Clinical Investigation|December 21, 2023
Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodelingSusan M Lin, Ryan Rue, Alexander R Mukhitov, et al.
American Journal of Human Genetics|October 10, 2025
COMPADRE: Combined pedigree-aware distant relatedness estimation for improved pedigree reconstructionGrahame F Evans, James T Baker, Lauren E Petty, et al.
Breast Cancer Research : BCR|October 26, 2023
Causal relationships between breast cancer risk factors based on mammographic featuresZhoufeng Ye, Tuong L Nguyen, Gillian S Dite, et al.
Nature Communications|November 7, 2020
mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function declineKseniya Obraztsova, Maria C Basil, Ryan Rue, et al.
The Journal of Biological Chemistry|June 14, 2000
Characterization of the human cysteinyl leukotriene 2 receptorC E Heise, B F O'Dowd, D J Figueroa, et al.
International Journal of Cancer|November 16, 2020
Novel mammogram-based measures improve breast cancer risk prediction beyond an established mammographic density measureTuong L Nguyen, Daniel F Schmidt, Enes Makalic, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitorP Prasit, Z Wang, C Brideau, et al.
Nature|July 3, 1999
Characterization of the human cysteinyl leukotriene CysLT1 receptorK R Lynch, G P O'Neill, Q Liu, et al.
Nature|July 14, 2000
Identification of receptors for neuromedin U and its role in feedingA D Howard, R Wang, S S Pong, et al.
Pageof 63